Dolocarp flavour, 50 mg, chewable tablet for dogs

Land: Irland

Sprog: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv bestanddel:

Carprofen

Tilgængelig fra:

aniMedica GmbH

ATC-kode:

QM01AE91

INN (International Name):

Carprofen

Dosering:

50 mg/tablet

Lægemiddelform:

Tablet

Recept type:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutisk gruppe:

Dogs

Terapeutisk område:

carprofen

Terapeutiske indikationer:

N.S.A.I.D.

Autorisation status:

Authorised

Autorisation dato:

2011-10-28

Produktets egenskaber

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dolocarp flavour, 50 mg, chewable tablet for dogs
Carprofen
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Chewable tablet.
Beige-brown tablets with a break-line.
The chewable tablet can be divided in two equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of inflammation and pain caused by acute and chronic
musculoskeletal disorders (e.g. osteoarthritis). As a
follow up to parenteral analgesia in the management of post operative
pain.
4.3 CONTRAINDICATIONS
Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in cases of hypersensitivity to active substance, to other
NSAIDs and to any of the excipients.
Do not use in animals suffering from cardiac, hepatic or renal
disease, where there is a possibility of gastrointestinal
ulceration or bleeding or where there is evidence of a blood
dyscrasia.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to sections 4.3 and 4.5.
Each chewable tablet contains:
ACTIVE SUBSTANCE:
Carprofen
50 mg
EXCIPIENTS:
Liver flavour liquid
2.5 mg
Special dry flavour vegetarian
25 mg
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_1_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_4_
_5_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR